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Abstract
Anionic amphiphiles such as sodium- and lithium dodecyl sulfate (SDS, LDS), or arachidonate (AA) initiate NADPH oxidase and proton
channel activation in cell-free systems and intact neutrophils. To investigate whether these amphiphiles exert allosteric effects on cytochrome
b, trisulfopyrenyl-labeled wheat germ agglutinin (Cascade BlueR–wheat germ agglutinin, CCB-WGA) was used as an extrinsic fluorescence
donor for resonance energy transfer (RET) to the intrinsic heme acceptors of detergent-solubilized cytochrome b. In solution, cytochrome b
complexed with the CCB-WGA causing a rapid, saturable, carbohydrate-dependent quenching of up to f 55% of the steady-state
fluorescence. Subsequent additions of SDS, LDS, or AA to typical cell-free oxidase assay concentrations completely relaxed the fluorescence
quenching. The relaxation effects were specific, and not caused by dissociation of the CCB-WGA–cytochrome b complex or alterations in
the spectral properties of the chromophores. In contrast, addition of the oxidase antagonist, arachidonate methyl ester, caused an opposite
effect and was able to partially reverse the activator-induced relaxation. We conclude that the activators induce a cytochrome b conformation
wherein the proximity or orientation between the hemes and the extrinsic CCB fluorescence donors has undergone a significant change.
These events may be linked to NADPH oxidase assembly and activation or proton channel induction.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Neutrophils and other phagocytes of the immune system
participate in protection of the host by engulfing and
destroying pathogens [1]. Central to this process is the
assembly of the NADPH oxidase complex at the neutrophil
plasma membrane. Currently, the oxidase is known to
comprise the cytosolic proteins, p40phox, p47phox, p67phox,
the membrane associated Rac1/2, Rap1A, and the trans-
membrane flavocytochrome b (a.k.a. flavocytochrome b558,
cytochrome b559, flavocytochrome b 245, and cytochrome
b) [2,3]. Flavocytochrome b serves as a locus for assembly
of the oxidase complex at the plasma membrane. In the
active NADPH oxidase complex, flavocytochrome b func-
tions as the terminal electron carrier for reduction of
extracellular molecular oxygen to the highly reactive super-
oxide anion (O2
) [2]. Superoxide then reacts with constit-
uents of the surrounding milieu to form a number of
microbicidal agents that are targeted to invading organisms.
The importance of a functioning NADPH oxidase in the
host immune response is demonstrated by individuals with
chronic granulomatous disease (CGD). Phagocytes from
these individuals are unable to mount an oxidative burst,
and in the absence of superoxide are unable to kill certain
types of organisms. This deficiency results in recurrent, life-
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threatening infections for the host. Genetic anomalies in
p47phox, p67phox, or flavocytochrome b are sufficient to
impair NADPH oxidase function [4].
The principal oxidase component is flavocytochrome b, a
bis-heme, heterodimeric protein composed of an extensively
glycosylated 91-kDa large subunit, gp91phox, and a 22-kDa
non-glycosylated small subunit, p22phox [5]. The intrinsic
noncovalently bound heme moieties [6] of flavocytochrome
b are localized to the NH2-terminal transmembrane domains
[7–9] and are believed to be essential for transmembrane
electron transfer [10,11] as well as proton conduction [8].
Flavocytochrome b binds both FAD [12] and NADPH [13],
suggesting that all of the necessary elements of the electron
transport chain are intact within cytochrome b alone, and
that the cytosolic subunits serve a regulatory role. This
proposition is supported by the work of Koshkin and Pick
[14], and later Doussie`re et al. [15], who showed that
purified, relipidated flavocytochrome b in the presence of
NADPH, FAD, and anionic amphiphile could sustain
limited superoxide production in the absence of the cyto-
solic subunits.
Since the introduction of the cell-free oxidase assay [16–
18], several studies have been undertaken to identify the
mechanisms that control oxidase activation. Under assay
conditions, recombining of cytosolic and membrane frac-
tions is generally insufficient to elicit oxidase activity.
However, upon addition of anionic amphiphiles such as
sodium dodecyl sulfate (SDS), lithium dodecyl sulfate
(LDS), or arachidonate (AA), the oxidase is activated in a
concentration-dependent manner. Although this system has
been used extensively to study the oxidase, the effects of the
amphiphiles are poorly understood and currently under
significant scrutiny.
Observations that the anionic amphiphiles induce con-
formational changes in the cytosolic subunits concurrent
with oxidase activation [19,20], combined with the discov-
ery of SH3 binding domains in both p47phox and p67phox
[21], led to the notion that the anionic amphiphiles might
function to expose certain protein domains. Once exposed,
interprotein interactions between the cytosolic subunits of
the oxidase as well as between the cytosolic subunits and
flavocytochrome b, were postulated to activate the oxidase.
In support of this hypothesis, truncated [22] or fusion
constructs [23] of p47phox and p67phox, or PKC-phosphory-
lated p47phox [24], were all shown able to partially activate
the oxidase in the absence of exogenous anionic amphiphile,
calling into question any role for the negatively charged
lipids. However, in all cases, oxidase activation was sub-
stantially less than that attainable when using wild-type
cytosolic subunits activated with SDS, suggesting that the
amphiphile-independent systems are incomplete. Moreover,
in the ‘‘amphiphile-independent’’ systems, reconstitution of
cytochrome b into lipid vesicles is accomplished with either
poorly defined lipid mixtures, known to be contaminated by
anionic lipids [25], or by purposely including acidic lipids
such as phosphotidylinositol (PI) or phosphotidylserine (PS)
[23] in the reconstitution mixture. Since these systems are
not truly amphiphile-free, the argument that the activity is
amphiphile independent is weakened considerably.
In situ interactions between the oxidase subunits, cofac-
tors, and lipids are even less clear, but have been postulated
to act in concert to alter the spatial relationships between the
cofactors, hemes, and the side chains of vicinal aromatic
amino acids of flavocytochrome b [26–28]. Together, these
studies suggest that oxidase activation within the cell
involves multiple protein–protein interactions that are
regulated through a combination of phosphorylation and
interactions with anionic lipids. Interestingly, practically
all notions of the activation process incorporate assump-
tions that conformational changes in flavocytochrome b
are ultimately responsible for establishing electron flow
from NADPH to oxygen via through-protein electron
tunneling [29,30] or more conventional means of electron
transfer.
Therefore, though it appears that anionic amphiphiles
directly affect the cytosolic subunits, such interactions do
not preclude the existence of important functional effects they
might have on membrane components of the oxidase.
Although the induction of an active state geometry of
flavocytochrome b has not been demonstrated directly, a
substantial amount of indirect evidence exists, deriving from
inhibitor, kinetic, oxygen affinity, electron spin resonance,
and atomic force microscopy studies. Paclet et al. [31] used
atomic force microscopy (AFM) to measure the size of
flavocytochrome b-containing liposomes before and after
addition of AA. Their data suggested a change in the
conformation of flavocytochrome b during the AA-mediated
transition from the inactive to the active state. Other studies
have shown that the accessibility of the flavocytochrome b
hemes to arsenic and cyanide derivatives [11] was influenced
by SDS and AA in parallel with a transition in the spin-state
of the heme iron [32]. These effects were concurrent with the
activation state of the oxidase in both cell-free systems,
utilizing membrane-bound flavocytochrome b, and intact
neutrophils [11,33]. Further analysis suggested the presence
of an amphiphile binding site on flavocytochrome b that,
once occupied, simultaneously decreased the affinity of
phenyl arsine oxide (PAO) for the hemes of flavocytochrome
b and increased the affinity of O2 [15]. Conformational
changes in flavocytochrome b have also been inferred from
kinetic studies of oxidase activation. Cross et al. [34], in their
study of oxidase activation by SDS andAA, proposed that the
lag in activity during the transition from what appeared to be
an intermediate state of oxidase activation to the fully ac-
tivated state could be explained by a change in the con-
formation of flavocytochrome b.
Additional studies support direct interactions between
flavocytochrome b and anionic amphiphiles. The lag period
prior to the onset of oxidase activity was shown to decrease
when cytosol and membrane fractions were preincubated
together with anionic activators, but not when incubated
separately [35,36]. Independently, Doussie`re et al. [15]
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observed that preincubation of membrane fractions with AA
increased both the rate and amount of superoxide produced,
while preincubation with the cytosolic fraction alone actually
impeded oxidase activation. Also, the cytosol-independent
oxidase activity observed by Koshkin and Pick [14] and
Doussie`re et al. [15] showed a strict dependence on anionic
amphiphile. Collectively, these observations suggest that the
amphiphiles interact directly with flavocytochrome b and are
involved with regulating oxidase activity.
To directly test the hypothesis that the oxidase activators
mediate the induction of an active-state geometry of cy-
tochrome b, we employed a system that was validated by
our laboratory for measurement of the distance between a
specific, fluorescently labeled, surface-exposed lysine and
the heme of cytochrome c [37]. In the present cytochrome b
system, we utilized wheat germ agglutinin (WGA), conju-
gated with the acetyl azide derivative of the trisodium salt of
1,3,trisulfo-8-pyrenyloxyacethydrazide, or Cascade BlueR
acetyl azide (CCB) [38] as an extrinsic fluorescence donor
(CCB-WGA). Since WGA binds tightly to cytochrome b via
the gp91phox glycan [5,39], the derivatized form, CCB-
WGA, should bind in the same manner and serve as an ex-
trinsic fluorescence donor for RET spectroscopic analyses of
detergent-solubilized, partially purified cytochrome b. When
prepared in this manner, the cytochrome b is depleted of the
optical cofactors, NADPH, and FAD [5], thus allowing the
intrinsic cytochrome b hemes to be used as the sole fluo-
rescence acceptors. This system can be used to detect minute
changes in the spatial relationships between the donors and
acceptors. Since all NADPH oxidase reconstitution assays
require anionic amphiphiles for full activity, we used this
RET system to directly measure their effects on cytochrome
b structure. Our results indicate that CCB-WGA is able to
form a stable complex with the gp91phox glycan in solution
and partially quench the probe fluorescence. This quench-
ing is relaxed by addition of the oxidase activators SDS,
LDS, or AA, suggesting that they interact directly with
cytochrome b to impart changes in the molecular geometry
of the protein. Moreover, these effects approached satura-
tion at activator concentrations consistent with maximal
activity in cell-free oxidase assays, and did not occur when
the methyl ester of arachidonate (AA-ME), an oxidase
antagonist [16], was substituted for the activators in our
RET system. Collectively, these observations suggest that
the structural changes induced in cytochrome b by the
activators are specific and saturable in a concentration range
consistent with their role in activation of the NADPH
oxidase.
2. Experimental procedures
2.1. Materials
KCl, NaCl, EDTA, NaN3, gelatin, [ethylenebis(oxyethy-
lenenitrilo)]tetra acetic acid (EGTA), syringe filters for
filtering buffers for fluorescence work (Whatman, 25-mm
diameter, polyethersulfone membrane, 0.2-Am pore size),
and sulfuric acid were purchased from Fisher Scientific
(Tustin, CA). N-acetylglucosamine (GlcNAc), N-NV-diace-
tylglucosamine (chitobiose), heparin–sepharose 4B beads,
N-formyl-Met-Leu-Phe, dihydrocytochalasin B, Na2 ATP,
chymostatin, WGA, diisopropylfluorophosphate (DFP), so-
dium dithionite, quinine sulfate, arachidonate or the methyl
ester suspended in chloroform, bovine serum albumin
(BSA), fetuin, ovalbumin (grade VI), proteinase K, Hanks
balanced salts, TRIZMA–HCl (Tris–HCL), 30% hydrogen
peroxide, ABTS, LDS, goat a-mouse IgG conjugated to
HRP, and Triton X-100 detergent were from Sigma Chem-
ical Co (St. Louis, MO). [N-(2-hydroxyethyl)piperazine-NV-
(2-ethanesulfonic acid)] (HEPES) and ultrapure SDS were
obtained from United States Biochemical (Cleveland, OH).
N-octyl-h-D-glucopyranoside (OG, octylglucoside), dithio-
threitol (DTT, Cleland’s reagent),and phenylmethylsulfonyl
fluoride (PMSF) were from Calbiochem-Novabiochem
Corp. (La Jolla, CA). CNBr-activated Sepharose 4B beads
were purchased from Pharmacia Biotech AB (Uppsala,
Sweden). Cylindrical, UV-transparent microcuvettes (6-
mm outside diameter) were purchased from Sienco, Inc.
(Fa¨rgelanda, Sweden). CCB-WGA conjugate was pur-
chased in lyophilized form from Molecular Probes (Eugene,
OR). The BCA protein assay, supplied in kit form, and
Reacti-BindR 96-well EIA polystyrene plates were from
Pierce, Inc. (Iselin, NJ).
2.2. Buffers
Buffer A consisted of 150 mM NaCl, 10 mM Na2PO4,
0.72 mM Triton X-100 (0.045%, or 3 critical micelle
concentration (CMC)), pH 7.4 and 0.02% NaN3, in deion-
ized water, filtered through a 0.2-Am pore size membrane
filter. Membrane resuspension buffer, MRB(), was made
as per the method of Parkos, et al. [5], and consisted of 10
mM NaCl, 100 mM KCl, 10 mM HEPES, 1 mM EDTA,
and 0.1 mM dithiothreitol, pH 7.4, in deionized water.
MRB(+) was MRB() supplemented with 1 mM PMSF
and 10 Ag/ml chymostatin immediately before use. Phos-
phate buffered saline (PBS) (10 mM) contained 10 mM
NaHxPO4, 150 mM NaCl, 0.02% NaN3, pH 7.4, in deion-
ized water. Digest buffer contained 50 mM Tris–HCl, pH
7.4, 10 mM MgCl2, and 0.02% NaN3 in deionized water.
Hanks balanced salt solution was purchased as a premeas-
ured dry powder and mixed as per manufacturer’s instruc-
tions. Relax(+) consisted of 10 mM NaCl, 100 mM KCl, 10
mM HEPES, 3.5 mM MgCl2, and 1.0 mM ATP, pH 7.4.
Buffers used for ELISA experiments were: 100 mM Phos-
phate Coupling Buffer (100 mM NaHxPO4 and 150 mM
NaCl in distilled water, pH 7.2), Blocking Buffer (100 mM
phosphate buffer supplemented with 0.05% Tween 20 and
3% BSA), Wash Buffer (10 mM HEPES, 150 mM NaCl in
distilled water, pH 7.4), and ABTS reagent (50 mM sodium
citrate in distilled water, pH 4.2 supplemented just before
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use with ABTS and hydrogen peroxide to final concentra-
tions of 455 AM and 0.1%, respectively).
2.3. Purification of cytochrome b
Isolation of human PMNs and purification of cyto-
chrome b were carried out as described by the method of
Parkos et al. [5]. Cytochrome b heme quantitation prior to
heparin purification was determined from the reduced minus
oxidized spectrum at 558 nm using De558 = 29.3 (mM
cm) 1 [40], blanked against control buffer, and reduced
by addition of sodium dithionite, mixed in deionized water
immediately prior to use, to a final concentration of 10 mM.
After heparin purification, cytochrome b heme quantitation
was carried out using e414 = 130.8 (mM cm)
 1 [40] blanked
against buffer. For RET experiments, the cytochrome b was
purified only to the heparin step. At this stage of the
purification the primary glycoprotein contaminant is Mac-
1 (CD11b/CD18). In preliminary studies, using more highly
purified preparations devoid of Mac-1 contamination (but
with significantly lower yields) [5,41], we found no meas-
urable difference in the degree of quenching or the stoichi-
ometry of CCB-WGA:cytochrome b required to achieve
maximum quenching. We concluded that the Mac-1 did not
contribute a significant degree of competitive binding for
CCB-WGA. The absorbance was measured on either a
Hewlett Packard HP 8452A diode-array spectrophotometer
or a Molecular Dynamics Spectra-Max 250, environmen-
tally controlled, microtiter plate spectrophotometer. When
necessary, the samples were sonicated using a Fisher 50
probe style Sonic Dismembrator, model XL2005.
2.4. CCB-WGA probe
The CCB-WGA probe was stored in the dark either in
lyophilized form at  20 jC with desiccant, or suspended at
1 mM concentration in 10 mM PBS, pH 7.4, aliquoted,
stored at  20 jC, and thawed immediately prior to use.
Quantitation of CCB-WGA was accomplished using
e400 = 31,400 (cm M)
 1 (Molecular Probes) for the CCB,
and the WGA content back-calculated using the labeling
stoichiometry average of 4.6:1, CCB/WGA (information
supplied by Molecular Probes). Immediately prior to use,
the probe was diluted in Buffer A to a working concen-
tration of 10 or 20 nM, based on WGA content, and filtered
through a 0.2-Am pore size syringe filter to remove partic-
ulate contamination. To prevent moisture condensation on
cuvettes, the working solution was brought to room temper-
ature before use.
2.5. Arachidonate
AA and AA-ME stocks in chloroform were stored at
 20 jC, in a sealed, dark container that had been purged
with argon. Working solutions were prepared by transferring
aliquots from the stock to a fresh tube where the chloroform
was removed by evaporation in a stream of ultra high purity
argon at room temperature. The amphiphiles were resus-
pended in deionized water by brief probe sonication, purged
with argon, and kept on ice prior to use. All working
solutions of AA and AA-ME were used the same day as
prepared.
2.6. Fetuin
The protein was weighed dry, suspended in buffer A, and
the concentration determined using the BCA method as
described by Pierce, compared to BSA standards. Fetuin
was prepared as an affinity ligand for the CCB-WGA probe
as described previously [42] except CNBr-activated Sephar-
ose 4B beads were purchased from Pharmacia Biotech, and
the ligand was coupled at 4 mg/ml as per manufacturer’s
instructions.
2.7. ELISA
Assays were conducted in 96-well maleic anhydride-
activated polystyrene Reacti-BindR plates. A 100-Al vol-
ume containing 2–10 Ag of WGA or CCB-WGA dissolved
in 100 mM phosphate Coupling Buffer was added to each
well and allowed to react overnight at room temperature (the
amount of WGA or CCB-WGA that bound to the wells was
determined by BCA assay to saturate at f 0.5 Ag/well for
both ligands). The wells were emptied and blocked by
exposure of each well to 200 Al of Blocking Buffer for 2
h at room temperature. The wells were then rinsed five times
with 250 AM LDS in Buffer A to displace any weakly
bound ligand, followed by five rinses with Buffer A.
Partially purified cytochrome b, 0.2–0.5 Ag heme (above),
in 100 Al of Buffer A was then added to each well and
incubated overnight at 4 jC. The plate was then rinsed five
times with Buffer A and the different concentrations of LDS
or AA dissolved in Buffer A were added. The plate was
allowed to incubate for 20 min at room temperature, and
then rinsed five times with Buffer A. One hundred micro-
liters of primary antibody, mAb 54.1 [43], at a concentration
of 2 Ag/ml in Blocking Buffer was added to each well. The
plate was then incubated at room temperature for 2 h and
rinsed five times with Wash Buffer. One hundred microliters
of goat a-mouse horse radish peroxidase conjugated IgG
secondary antibody was added per well at a 1:1000 dilution
in Blocking Buffer and incubated for 1 h at room temper-
ature. The plate was then rinsed five times with Wash Buffer
and developed by adding 100 Al of ABTS reagent per well.
Absorbance values were measured at 405 nm.
2.8. Fluorescence measurements
All reagents containing CCB-WGA were kept in foil-
wrapped containers and solutions containing cytochrome b
or lipids were kept on ice prior to use. Experiments were
conducted at ambient temperature in cylindrical 6-mm out-
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side-diameter 500-Al continuously stirred UV transparent
microcuvettes. Fluorescence measurements were recorded
using a Photon Technologies Inc. Quanta-Master QM-1
steady state fluorometer with excitation monochromators
set at 376 nm and the emission monochromator set at 418
nm for kinetic measurements. The slit width for both mono-
chromators was set at 2 mm, corresponding to 4- and 8-nm
bandpass for the excitation and emission monochromators,
respectively. All fluorescence spectra were corrected for the
wavelength-dependent instrument response using the soft-
ware functions provided by the manufacturer (Felix software
ver 1.1, 1996 PTI, Inc). For all experiments the CCB-WGA
working solution (10 or 20 nM) was introduced to a con-
tinuously stirred cuvette, and the fluorescence monitored for
a short period prior to addition of other constituents. Cyto-
chrome b was added with either a Hamilton syringe or a
Pipetteman micropipetter directly to the stirred cuvette. All
experimental data shown represent averages or typical results
from at least two independent experiments on different
preparations or from different days. All fluorescence values
were corrected for dilution effects from changes in cuvette
volume due to reagent addition. Fluorescence quenching
curves were transformed by first subtracting the baseline
fluorescence, and then the absolute values of the fluorescence
change were fit to a ‘‘one-phase exponential association’’
curve by nonlinear regression using the equation Y= Ymax
(1 e kx), where Ymax represents the fluorescence at satu-
ration of the quenching effect. Fluorescence relaxation curves
were also transformed by subtracting the baseline fluores-
cence, and the resulting values were fit to a ‘‘1-site binding
hyperbola’’ curve from which the binding parameters of the
anionic amphiphiles were calculated. All curve-fitting anal-
yses were performed using GraphPad Prism version 3.02 for
Windows (GraphPad Software, San Diego, CA USA,
www.graphpad.com., Copyright (c) 1994–1999 by Graph-
Pad Software. All rights reserved).
2.9. RET distance calculations
Fo¨rster distance calculations were determined as de-
scribed [44,45] assuming a K2 value of 2/3, and a refractive
index of 1.44. R0 for the CCB-WGA probe was calculated at
47 A˚ allowing a useful range of approximately 25 to 90 A˚
for distance estimates between the donor and acceptor
molecules. The quantum yield of the CCB-WGA molecule
was determined by the method outlined by Parker and Rees
[46] using quinine sulfate in 0.1 N H2SO4 as a reference
standard, quantitated using e346 = 1.09 104, with a quan-
tum yield = 0.51F 0.03 if A346 < 0.02 AU ( < 1 AM) [47].
Since the CCB labeling sites on the WGA are unknown, we
assumed a spherical shape with a diameter of 50 A˚,
corresponding to an average axial dimension of the WGA
molecule as determined from X-ray crystal coordinates [48].
Due to the intrinsic planar symmetry of the heme molecule,
the orientation relative to the donor dipole imposes at most a
20% error in any distance approximations [49].
3. Results
3.1. Resonance energy transfer (RET) between trisulfopyr-
enyl-labeled WGA and the heme(s) of cytochrome b
A fluorescent conjugate of WGA, CCB-WGA, was used
as a nonperturbing, extrinsic fluorescence donor molecule
for RET to the intrinsic heme ligands of cytochrome b. This
system was used to monitor changes in the structure of
detergent-solubilized cytochrome b during exposure to the
oxidase activators AA, SDS, and LDS. The efficiency of the
energy transfer, or in this instance, the degree of steady-state
fluorescence quenching, allowed estimation of the average
radial distance separating the donor–acceptor pairs based on
Fo¨rster theory [44] (see Section 2). Fig. 1 shows the spectral
overlap between the normalized CCB-WGA fluorescence
emission spectrum (kex = 376 nm, solid line) and the Soret
absorbance profile of the oxidized heme prosthetic groups
of cytochrome b (dashed line). The spectrally matched
properties of the donor–acceptor pair satisfy the criteria
required for RET [44,50] characterized by an R0 value of 47
A˚, the distance at which 50% of the donor fluorescence
would be quenched.
Addition of partially purified cytochrome b (f 7.5 nM)
in a single aliquot to Buffer A containing 20 nM CCB-
WGA conjugate, resulted in partial quenching of the CCB
fluorescence (Fig. 2A). Titration of solutions containing
CCB-WGA with aliquots of cytochrome b (Fig. 2B) caused
a saturable, concentration-dependent quenching of up to
53.9F 1.8% (n = 4) of the initial fluorescence. This value
was somewhat variable (f 20%) among blood donors and
was inversely dependent on the age of the membrane ex-
tract. Based on Fo¨rster calculations, this degree of quench-
ing is consistent with an average CCB to heme radial
Fig. 1. Overlap of Cascade BlueR fluorescence and cytochrome b
absorbance spectra. Normalized oxidized Soret absorbance spectrum of
cytochrome b (dotted line) in buffer A with kmax at 414 nm. Emission
spectrum of Cascade BlueR dye when covalently bound to wheat germ
agglutinin (CCB-WGA) (solid line) in buffer A, with kex = 376 nm and kem
maximum at 418 nm.
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distance of 45.8F 0.5 A˚. Reverse titration of cytochrome b
with CCB-WGA produced an analogous effect (not shown).
Experimental concentrations of both the CCB-WGA and the
cytochrome b were 10 to 40 nM, well below the level where
any significant inner-filter effects would occur (for kex = 376
nm, A376 < 0.001 AU for both CCB and cytochrome b) [45].
Also, addition of 10 nM cytochrome b to solutions contain-
ing an equimolar amount of an CCB-ethanolamine conju-
gate (Fig. 2A, inset) caused only a slight reduction in the
fluorescence intensity, reflecting only dilution effects from
cytochrome b addition. This control result indicated that any
inner-filter effects were inconsequential to the observed
fluorescence quenching and that the charged trisulfonic acid
moieties of the CCB molecule did not promote nonspecific
ionic interactions between the molecules. Addition of CCB-
WGA to cytochrome b had no effect on the heme absorb-
ance spectrum (not shown) or the shape of the CCB-WGA
fluorescence emission spectrum (Fig. 2B, inset), indicating
that formation of the CCB-WGA–cytochrome b complex
neither perturbed the heme environment nor changed the
intrinsic spectral properties of the CCB. Together, these data
suggested that the fluorescence quenching effect was due to
RET between the donor–acceptor pairs, similar to our
previous work with cytochrome c [37].
3.2. The interaction between the CCB-WGA conjugate and
cytochrome b is a lectin–carbohydrate specific interaction
Native WGA has been shown to have both high affinity
and specificity for GlcNAc and its multimers, and to a lesser
extent, N-acetyl-neuraminic acid (sialic acid, NeuNAc) [51].
To confirm that the same ligand specificity was retained
between CCB-WGA and cytochrome b, we examined the
effects of GlcNAc or the dimeric form, N-NV-diacetylglucos-
amine (chitobiose), or NeuNAc in both competition (Fig. 3)
and inhibition assays (not shown). Addition of chitobiose to
a final concentration of 400 Ag/ml (942 AM) to solutions
containing 20 nM CCB-WGA previously complexed with
cytochrome b resulted in a rapid, total reversal of the
fluorescence quenching (Fig. 3). Complete inhibition of
Fig. 3. Chitobiose reverses CCB-WGA fluorescence quenching by
cytochrome b. The effect of chitobiose on the fluorescence of 20 nM
CCB-WGA in the presence of 7.5 nM cytochrome b. At 3 min, chitobiose
dissolved in Buffer A is added in a single aliquot to a final concentration of
400 Ag/ml (942 AM) to the stirred cuvette. Fluorescence quenching is
rapidly reversed indicating competitive dissociation of the CCB-WGA,
cytochrome b complex.
Fig. 2. Quenching of CCB-WGA fluorescence by addition of cytochrome b.
(A) The effect of addition off 7.5 nM cytochrome b on the fluorescence of
20 nM CCB-WGA in buffer A (kex = 376 nm, kem = 420 nm). Time 0–1
min is the initial CCB-WGA fluorescence in the absence of cytochrome b.
At 1 min, partially purified cytochrome b is added to the stirred cuvette and
the fluorescence is monitored for a total of 30 min. (Inset) A control
consisting of cytochrome b added to free CCB dye. Time 0–1 min is the
initial fluorescence of 20 nM CCB. At 1 min a single 20-Al aliquot of
cytochrome b (0.5 AM heme) is added (final concentration of f 20 nM) to
the cuvette. The fluorescence is decreased by f 4%, consistent with the
dilution from the change in cuvette volume. (B) Concentration dependence
of fluorescence quenching of 20 nM CCB-WGA by cytochrome b. Single
2-Al aliquots of partially purified cytochrome b (0.85 AM) were added to a
stirred cuvette containing 20 nM CCB-WGA. Following each addition of
cytochrome b, the effects were allowed to equilibrate and the fluorescence
was measured. These data were transformed by subtracting the baseline
fluorescence and then plotting (.) the resultant absolute valuesF S.E.M
(n= 4). The transformed values were fit to a curve (: : :) as described in
Section 2. At saturating concentrations of cytochrome b, the CCB-WGA
fluorescence would be quenched a maximum of 53.9F 1.8%, correspond-
ing to an average heme to CCB moiety distance of 45.8F 0.5 A˚. (Inset) The
shape of the CCB-WGA emission spectrum remains unchanged after
addition of cytochrome b. CCB-WGA fluorescence emission spectrum (20
nM) (kex = 376 nm) is recorded before (upper trace) and after addition of 20
nM cytochrome b (lower trace).
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quenching was also observed when chitobiose was added to
CCB-WGA prior to cytochrome b (not shown). In contrast,
concentrations of GlcNAc or NeuNAc, up to 1 mM, were
ineffective in either reversal or inhibition of the quenching
of the CCB-WGA fluorescence by the cytochrome. More-
over, addition of either ligand to the CCB-WGA alone had
no effect on the fluorescence (not shown). These observa-
tions reflect the differences in the IC50 concentrations for
chitobiose (0.15 mM), GlcNAc (12.5 mM), and NeuNAc
and sialic acid (25 mM) for inhibition of agglutinating
activity by WGA [52]. Since cytochrome b has a high
GlcNAc content [39], these results suggest that formation
of the CCB-WGA–cytochrome b complex and subsequent
quenching is due to a lectin–carbohydrate interaction
between the CCB-WGA and multimeric GlcNAc on
gp91phox.
Reversal of quenching by addition of chitobiose was
accompanied by an f 10% increase in the fluorescence
beyond the initial amount prior to quenching (Fig. 3). The
increase was attributed to relaxation of a small amount of
intramolecular quenching in the conjugated WGA (4.6 CCB
per WGA dimer) upon its binding to complex sugars based
on experiments utilizing other glycoproteins and proteinase
K-digested cytochrome b [41]. Together, these experiments
suggest that the amount of intermolecular quenching of
CCB-WGA fluorescence by cytochrome b, described above,
might be a slight underestimate.
Fig. 4. LDS relaxes CCB-WGA fluorescence quenching by cytochrome b.
The effect of addition of LDS to 20 nM CCB-WGA in Buffer A previously
quenched by addition of 20 nM cytochrome b. (A) Time 0–2 min is the
cytochrome b-quenched CCB-WGA fluorescence. Beginning at 2 min,
successive 1-Al aliquots (arrows) of 10 mM LDS (f 17.5 AM final
concentration) were added to the stirred cuvette to a final concentration of
f 100 AM. (Inset) Addition of a single aliquot of LDS (arrow) to a final
concentration of f 120 AM to CCB-WGA alone in Buffer A has no
measurable effect on the probe fluorescence. (B) The fluorescence intensity
was measured immediately before each successive addition of LDS from
panel A. These data were transformed by subtracting the baseline
fluorescence, and the values were plotted (n). The resulting plot was fit
to a 1-site binding isotherm (: : :) as described in Section 2. The Kd for LDS
was calculated to be 129.2F 17.4 AM (R2 = 0.9977), and extrapolation to
the saturating concentration of LDS indicates that the fluorescence
quenching would be completely relaxed.
Fig. 5. AA relaxes fluorescence quenching of CCB-WGA by cytochrome b.
The effect of addition of AA to 20 nM CCB-WGA in buffer A previously
quenched by addition of 20 nM cytochrome b. (A) Time 0–2 min is the
cytochrome b-quenched CCB-WGA fluorescence. Beginning at 2 min,
successive 1-Al aliquots (arrows) of 10 mM AA (f 17.5 AM final
concentration) were added to the stirred cuvette to a final concentration of
f 100 AM. (Inset) Addition of a single aliquot of AA (arrow) to a final
concentration f 300 AM toCCB-WGA alone in Buffer A has nomeasurable
effect on the probe fluorescence. (B) Fluorescence intensity measurements
made immediately before each successive addition of AAwere transformed
by subtracting the baseline fluorescence, and the valueswere plotted (n). The
resulting plot was fit to a 1-site binding isotherm (: : :) as described in Section
2. The Kd for AA was calculated at 93.1F11.5 AM (R2 = 0.9965), and
extrapolation to the saturating concentration of AA indicates that the
fluorescence quenching would be completely relaxed.
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3.3. Fluorescence quenching of CCB-WGA by cytochrome b
is relaxed by SDS, LDS, and AA
Most cell-free NADPH oxidase assays require addition
of either SDS or LDS to initiate activity [53]. AA is another
potent activator of O2
 production and proton channel
conductance by the NADPH oxidase when introduced either
exogenously to intact phagocytes [54,55], or in cell-free
systems [16], where it has been shown to interact directly
with cytochrome b [15]. We thus exploited our system to
investigate whether interactions between the activators and
cytochrome b induce structural changes in the cytochrome
that would be apparent as changes in the RET efficiency.
Addition of aliquots of LDS (Fig. 4A, arrows), SDS (not
shown), or AA (Fig. 5A, arrows) to CCB-WGA previously
quenched by cytochrome b resulted in a concentration-de-
pendent relaxation of the fluorescence quenching, with the
effect approaching saturation at concentrations consistent
with maximal cell-free oxidase system activity. The fluo-
rescence values resulting from each successive addition of
the activators were recorded after equilibrium was reached
(Figs. 4B and 5B) and fit to a binding isotherm modeling a
1-site binding interaction (see Section 2). Under these
conditions, the Kd values for SDS, LDS, and AA were
calculated to be 44.6F 4.8, 129.2F 17.4, and 93.1F11.5
AM, respectively. Controls of SDS (not shown), LDS, or AA
(Figs. 4A and 5A, insets), added to CCB-WGA alone had
no effect on the fluorescence intensity of the probe. Addi-
tional experiments with SDS additions to 1.75 mM (SDS
CMC= 1.33 mM) to the CCB-WGA also had no effect on
the probe fluorescence (not shown). These results indicate
that the CCB-WGA fluorescence is insensitive to high con-
centrations of anionic detergent.
The methyl ester of arachidonate (AA-ME) is unable to
elicit NADPH oxidase activity in either whole cells or cell-
free assays, and has been shown to competitively counteract
AA-mediated oxidase activation [16,56]. If the activator-
induced relaxation effects were linked to oxidase activation,
then addition of AA-ME to our RET system should cause
dissimilar effects, and possibly be able to counteract those
of AA. Indeed, in contrast to AA, LDS, or SDS, addition of
AA-ME to CCB-WGA previously quenched with cyto-
chrome b failed to relax the quenching and actually caused
a slight decrease in the steady-state fluorescence (Fig. 6A).
Furthermore, when AA-ME was added after AA to the
previously quenched CCB-WGA, the fluorescence relaxa-
tion effects from the AA were partially reversed (Fig. 6B).
3.4. Relaxation of fluorescence quenching is not due to
dissociation of the complex or alterations in heme spectrum
ELISA experiments were conducted next to ensure that
the activator-induced fluorescence relaxation was not due to
dissociation of the CCB-WGA complex. Cytochrome b was
added to wells containing covalently bound CCB-WGA
(Fig. 7) or WGA (not shown). Different concentrations of
LDS or AA were added to the wells in buffer conditions
analogous to the RET experiments and over the same time
frame. The wells were then probed with a-gp91phox mAb
54.1 [43]. Exposure of the WGA or CCB-WGA–cyto-
chrome b complex to either LDS or AA at concentrations
up to 100 AM had little effect on the ELISA signal. At
activator concentrations between 100 and 150 AM, both
activators caused a partial loss of signal. Additionally, 120
AM SDS had no effect on the ability of CCB-WGA to either
bind immobilized fetuin, or to be eluted by chitobiose from
this affinity matrix (not shown). These results indicate that
the activator-induced quenching relaxation (Figs. 4 and 5)
was not due to dissociation of the CCB-WGA–cytochrome
b complex.
Interactions between the activators and cytochrome b
might also perturb the heme environment thereby affecting
the Soret absorbance spectrum. The consequent changes in
the spectral overlap between the donor–acceptor pair would
Fig. 6. AA-ME has the opposite effect of AA on fluorescence quenching. (A) The effects of addition of AA-ME on the fluorescence of CCB-WGA previously
quenched by cytochrome b. Time 0–2 min is the fluorescence of 20 nM CCB-WGA previously quenched by exposure to 20 nM cytochrome b for 20 min.
Beginning at 2 min, successive 1-Al aliquots (arrows) of 10 mM AA-ME (f 17.5 AM final concentration per aliquot) were added to the stirred cuvette to a final
concentration off 100 AM. The fluorescence intensity is diminished slightly with each addition, an effect opposite of that observed with LDS, SDS, or AA.
(B) The reversal of the AA-induced relaxation effects by addition of AA-ME. Time 0–2 min is the fluorescence of 20 nM CCB-WGA previously quenched by
exposure to 20 nM cytochrome b for 20 min. At 2 min a single 2-Al aliquot of 10 mM AA (f 35 AM final concentration) was added to the stirred cuvette and
allowed to equilibrate for 20 min. Beginning at 22 min, successive 2-Al aliquots (arrows) of 10 mM AA-ME (f 35 AM per aliquot) were added to the stirred
cuvette to a final concentration of f 140 AM. The AA-induced quenching effects are partially reversed by addition of AA-ME.
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contribute to the observed quenching relaxation. However,
exposure of cytochrome b to 100 AM SDS or AA had no
effect on the Soret absorbance spectrum over a 20-min
period in buffer conditions identical to the RET experiments
(not shown). In contrast, at SDS or AA concentrations
greater than f 160 AM, the Soret absorbance maximum
was blue-shifted from 414 to 408 nm, concomitant with a
reduction in the overall absorbance, and a loss of the 558 nm
a-band following dithionite reduction (not shown). These
observations suggested that activator concentrations greater
than f 160 AM perturbed the native heme environment,
probably by nonspecific detergent-like interactions. These
results correlated well with previous studies that showed
maximum oxidase activity occurring at approximately 100–
120 AM SDS or AAwith higher concentrations correspond-
ing to a sharp decline [16,57].
4. Discussion
Our RET system utilized Triton X-100-solubilized, par-
tially purified human neutrophil cytochrome b that was free
of spectral interference from flavin or NADPH cofactors,
both of which have intrinsic fluorescence and absorbance
spectral overlaps with CCB. Detergent solubilization also
circumvented the complexities of inter-cytochrome b RET
due to aggregation or close proximity within the liposome,
or orientation relative to the bilayer. By eliminating these
confounding variables from our system, the RET effects that
we observed could be interpreted within the context of a
simplified donor–acceptor system consisting solely of
CCB-WGA and monodisperse cytochrome b. At this degree
of purity, the cytochrome b is capable of reconstituting
defective respiratory burst activity in detergent extracts of
neutrophil membranes obtained from patients with the
autosomal and X-linked forms of CGD [58]. In addition,
it is able to bind the low molecular weight G protein rap1A
in a phosphorylation-dependent manner [59]. Most impor-
tantly, it displays both oxidized and reduced heme absorb-
ance spectra identical to that of lipid-bound flavocyto-
chrome b, indicating a native heme environment. Thus,
the detergent-solubilized cytochrome b used for these ex-
periments represents a reasonable model of membrane-
bound flavocytochrome b.
Our results suggest that functionally relevant structural
rearrangements do indeed occur within cytochrome b con-
current with exposure to activators at concentrations rou-
tinely used to initiate NADPH oxidase activity in vitro.
The results derive from a novel RET system that exploits
the high affinity lectin–carbohydrate interaction between
CCB-WGA and the carbohydrate of gp91phox to form a
complex. Within this complex, the CCB moieties are po-
sitioned close enough to the intrinsic cytochrome b hemes
to allow direct transfer of electronic excitation energy.
Consequently, up to f 55% of the CCB fluorescence is
quenched, and subsequent additions of the anionic amphi-
philes LDS, AA, or SDS to the complex relax the quench-
ing, implying a change in the spatial relationships (distance,
orientation) between the donor–acceptor pairs.
The different anionic amphiphilic oxidase activators
cause very similar effects on RET in the CCB-WGA/
cytochrome b heme system; they completely restore the
CCB-WGA fluorescence from the cytochrome b-quenched
state. The complete relaxation of quenching at the calculated
saturating concentrations of LDS, SDS, or AA to this RET
system, corresponds to an apparent displacement between
the CCB-WGA and a cytochrome b heme of roughly a
minimum of 20–30 A˚, based on Fo¨rster distance calcula-
tions (see Section 2), assuming there is a 5–10% residual
quenching after addition of the anionic amphiphiles. Since
these effects appear to occur without perturbation of any of
the chromophores of the system, they probably arise from
rearrangements between inter- or intra-cytochrome b
domains in combination with reorientation of the heme
dipoles [8,60] relative to the CCB donors. Such large
rearrangements have been measured in other heme-bearing
systems such as nitric oxide synthase oxygenase and the
Reiske ironsulfur protein of the mitochondrial cytochrome
bc1 complex [61,62].
The changes we observe might also be due to the
activators interacting with domains of the protein that are
not directly linked to oxidase or proton transport activity.
However, the inability of AA-ME (Fig. 6), an antagonist of
AA in cell-free assays [15], to induce effects similar to AA
Fig. 7. ELISA of cytochrome b bound to immobilized CCB-WGA after
exposure to LDS and AA. Cytochrome b was bound to immobilized CCB-
WGAon an ELISA plate under essentially the same conditions and buffers as
in the RET assays. The complexes were then exposed to varying
concentrations of AA or LDS and probed with an a-cytochrome b mAb as
described in Section 2. Shown are the relative amounts of cytochrome b
bound to the immobilized CCB-WGAF S.D. from two separate experiments
with each concentration of either LDS (black bars) or AA (gray bars) done in
triplicate. Data are expressed as percent of control wells that contained only
Buffer A. No significant change in the amount of cytochrome b bound by the
CCB-WGA is observed at the 100 AM experimental concentrations of either
activator. Activator concentrations of 150 AM reduce the amount bound by
approximately 25% for LDS and 14% for AA.
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would argue against this premise. Also, the activator-in-
duced effects (Figs. 4 and 5) approach saturation at concen-
trations consistent with those shown to elicit maximal
activity in cell-free oxidase assays [16,57]. This saturable
behavior further suggests specific binding, thus corroborat-
ing previous observations [15].
Anionic amphiphile-induced structural changes in cyto-
chrome b may also relate to events observed in the cell.
Specifically, AA has been shown to be liberated from the
phagocyte membranes following receptor-mediated activa-
tion, suggesting it may mediate both oxidase [63,64] and
proton channel activity [65]. AA appears to be liberated
from phospholipids by the action of cPLA2 [66] under the
control of a MAP kinase [67]. A human myeloid cell line
deficient in cPLA2 was unable to activate the oxidase in
response to various stimuli until supplemented with exog-
enous AA [68], and inhibitors of cPLA2 were also shown to
inhibit the oxidative burst [67]. Synthetic analogues of
endogenous neutrophil lipids other than AA also have been
shown to either synergize with SDS and AA, or act alone as
activators in cell-free oxidase systems [69,70].
A second body of evidence suggests that membrane-
phospholipid-derived AA may also be involved with
regulation of the proposed gp91phox proton channel func-
tion [65,71]. Most recently, proton channel activation has
been proposed to be directly linked to release of heme
from one of its putative ligands, His115 of gp91phox [8].
Changes in histidine ligation during oxidase activation
might provide a mechanism that would couple electron
and proton transport activities. These lines of investigation
strongly implicate the anionic amphiphiles in induction of
structural changes in flavocytochrome b. Such changes
may promote productive interactions between the cytosolic
subunits and flavocytochrome b, thereby enabling full
oxidase activation, or possibly directly affect the function
of flavocytochrome b.
Preliminary results from testing certain lipid effectors on
our system, chosen based on their ability to elicit superoxide
generation in vitro [72], showed that certain phosphatidic
acids (PAs) but not diacylglycerols caused effects similar to
SDS, LDS, and AA [41]. Thus, LDS, SDS, AA, and specific
PAs possess similar characteristics that may define the
requirements for effector action within our system: an
anionic head group and either an unsaturated, or restricted
length saturated fatty acid component, paralleling previous
observations [16]. The similar effects imparted by these
different activators on the RET system correlates well with
their biochemical effects within the context of oxidase
activation. Thus, we believe they represent specific, func-
tionally relevant effects.
Numerous investigators have postulated that structural
changes in flavocytochrome b are a key step in oxidase
activation [15,23,25,31,34,73–79]. Our observations corrob-
orate this supposition, offering new insight into the complex-
ities of oxidase activation and providing a foundation for
further investigation of the link between flavocytochrome b
structural changes and regulation of transmembrane electron
and proton conduction. The deficiencies of the cytosol- or
amphiphile-independent oxidase systems might very well be
reconciled in a system where phosphorylation events and
amphiphile interactions with several of the oxidase subunits
combine to effect full activity. The RET system also provides
a means to monitor the induction of functionally relevant
structural changes in cytochrome b arising from interactions
with specific compounds other than those tested in this work,
or possibly, the oxidase subunits.
In preliminary efforts [41] we have extended the scope of
these experiments to include utilization of fluorescently
labeled, cytochrome b-specific monoclonal antibodies with
known epitope interactions as donor molecules, allowing
investigation of changes in the spatial relationships between
specific epitopes and the hemes, potentially in intact cells or
isolated neutrophil membranes. In such systems, we have
observed similar quenching effects from extracellular and
intracellular binding sites on both detergent-solubilized cy-
tochrome b and membrane-bound flavocytochrome b.
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